© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Back in the early 1900s, fever and pain meant using what you had, and aminopyrine sat front and center. German chemists crafted this compound as a synthetic fever-reducer and painkiller. Demand shot up through the decades because people needed affordable, effective relief for everyday discomfort. Medical breakthroughs lived in crowded, busy hospitals, and aminopyrine routines offered a straightforward tool. Its popularity stretched from Europe to Asia and landed heavily across pharmacies worldwide. Then, over time, its reputation took a hit as researchers noticed serious side effects, especially potential changes in blood; regulatory agencies moved to restrict its medical use. The story of aminopyrine reads like a warning and a lesson in staying on top of drug safety even after years of trusted use.
Aminopyrine belongs to the pyrazolone class, delivering quick action for pain and fever. Pharmacies stocked it as tablets, powders, and injections. Veterinary and industrial fields tapped into variations for research and analytical chemistry, showing versatility outside traditional medicine. Its bitterness stood out, so patients often reached for water afterward. The drug’s recognizable taste made it easy to spot for anyone who tried it even once, which sometimes helped with medication adherence back in the days of looser enforcement.
Aminopyrine forms white to pale-yellow crystals, dissolving easily in organic solvents and sparingly in water. With a melting point near 110°C, it could weather ordinary transport conditions. Chemically, its IUPAC name—4-dimethylaminoantipyrine—reflects its structure built off a pyrazolone core with methyl and amino groups attached. That build gave aminopyrine the pharmacological punch needed back then for clinical effect. It measured up with a molecular formula of C13H17N3O, and under lab filters, its faintly sweet aroma exposed minor impurities. Handling unrefined samples often meant catching the faint chemical scent and chalky residue on fingertips until the batch cleaned up.
Decades of production meant learning to watch label details. Labels carved out exact weight per dose, purity percentages, possible fillers, and the country of origin. Users checked for batch numbers and expiry dates—a necessary habit after cases of spoiled batches led to headaches for both patients and regulators. Some countries required black-box warnings over risk for blood abnormalities, pointing to agranulocytosis. In regulated supply chains, detailed documentation followed every lot, from raw ingredient intake to final packaging, and quality labs double-checked using TLC and melting point testing before greenlighting batches.
The main route starts with antipyrine, itself a pyrazolone. By using methylation and reacting with dimethyl sulfate or methyl iodide, chemists tacked on the dimethylamino group at the right location on the antipyrine molecule. Each batch relied on precise controls for temperature and reagent addition, as too much heat or poor mixing could drop yield or bring up unwanted byproducts. After the main reaction, purification demanded careful crystallization to weed out leftover reagents and secure medication-grade standards. Large manufacturers used column chromatography and advanced solvent systems, but the basics—careful mixing, patience, and testing—held just as true in small-scale setups used in teaching labs.
Aminopyrine undergoes noticeable changes when treated with oxidizing agents; this quality underpins many colorimetric assays in research labs today. Chemists tinker with the parent compound, attaching other substituents for shifting activity or solubility. Metabolism research on this molecule—often tagged with radioactive carbon—unlocked secrets about how human livers handle N-demethylation and conjugation, leading to more precise dosing recommendations. Modifications led the way for analogues like metamizole with reduced side-effect profiles, showing why ongoing research into chemical tweaks drives progress for safer drugs.
Anyone leafing through old pharmacopoeias runs into a stack of names for the same core medicine. Amidopyrine, Pyramidon, Dimethylaminoantipyrine, and even Aminopyrinum show up depending on language or manufacturer. Pharmacies in the mid-20th century stocked Pyramidon tablets under bright, optimistic packaging, signaling relief for common aches and fever. Each synonym carries its baggage and local reputation, but all point back to the original German blueprint that launched its global journey.
Over time, real-world reports and lab findings underscored the risks of aminopyrine, especially involving blood cell changes. Doctors and pharmacists learned the hard way to take patient histories and flag reactions at the first sign of sore throat or fever not tied to the original illness. Regulations in Europe and North America now demand warnings against its use for most people, reserving it for settings with close medical oversight. Lab workers handling aminopyrine samples wear gloves, work with fume hoods, and tightly seal waste containers, knowing accidental exposure can lead to skin irritation or more serious consequences. Moving to safer compounds for routine use became standard after better options showed the same benefits with far less risk.
Aminopyrine lost most of its presence in human clinics, but it serves as a research tool and a veterinary agent in some places. Animal medicine sometimes leans on aminopyrine for pain control or fever reduction in livestock. Analytical chemists count on it for robust lab assays—specifically for liver function testing through breath analysis of labeled derivatives. In schools and universities, it gets pulled off the shelf for demonstration of classical organic synthesis techniques, allowing new chemists to learn the principles underlying a century-old workhorse.
Work on aminopyrine never fully stopped, despite tighter use restrictions. Today’s labs probe its metabolism, studying how genetic differences influence side effects and response rates. Ongoing research into alternatives and analogues owes its foundation to tracking what aminopyrine does well and where it falls short. Development teams keep pushing for modifications that deliver the useful parts—quick fever or pain relief—while shedding the blood problems. Published safety studies provide invaluable training tools for scientists and clinicians learning to weigh risk versus benefit and track even rare adverse effects in real time.
Published findings hammered home the link between aminopyrine and blood dyscrasias, especially the catastrophic drop in neutrophil count called agranulocytosis. Observational studies connected dots between genetic factors, concurrent use of other drugs, and pre-existing viral infections as amplifiers of risk. Toxicologists mapped metabolic pathways, noting that specific breakdown products trigger immune reactions harmful to bone marrow. These lessons have shaped regulatory thinking worldwide, pressing for closer post-marketing surveillance for all new drugs—not just those discovered decades ago. Forensic labs now rely on accurate aminopyrine detection in cases of unexplained fevers or drug reactions.
The old standard finds itself woven into educational materials and referenced often in pharmaceutical safety lectures. New derivatives—built off the same core but heavily modified—stay in the pipeline, aiming to deliver rapid relief without the baggage. Pharmaceutical companies put heavy emphasis on pharmacogenomics as part of the future, tracking patient genetics to suggest safer, more precise dosing. The history and ongoing technical research around aminopyrine frame a case study in adaptation, where vigilant records and improved monitoring guard against repeating past mistakes, and where small chemical changes can change lives for the better. The road ahead will see aminopyrine less as a drug for daily use and more as a legacy molecule guiding safer science.
Aminopyrine once sat front and center on pharmacy shelves across the world. In my college pharmacology classes, old textbooks described it as a gold standard for cutting through pain and lowering fever. It worked fast. Headaches, muscle aches, dental pain — aminopyrine used to cover them all. It belonged to a group we now call non-opioid analgesics. Looking back at family stories, I recall hearing how it could kill not just pain, but also that sense of desperation people get when they can’t sleep because everything hurts.
At some point, the story around aminopyrine changed completely. Reports began to stack up about people developing agranulocytosis. This word rarely made its way into everyday conversation, but its meaning did: severe, sudden loss of white blood cells. Even one dose could trigger a reaction. Instead of fixing problems, aminopyrine sometimes sent people to hospitals with life-threatening infections. I heard of doctors who’d seen it too many times, and would never prescribe it again.
By the late seventies, regulators in Europe, the U.S., and other countries pulled aminopyrine from the market. Medical journals published statistics showing the links between its use and dangerously low immune cell counts. In many countries, it is now banned. Over-the-counter painkillers like acetaminophen and ibuprofen replaced it quietly, with fewer stories of devastating side effects.
Not every country banned aminopyrine completely. South America, the Middle East, and some parts of Asia still see it used in certain prescription medications. Doctors there face a choice between cost, tradition, and alternatives.
Aminopyrine works well for short-term pain in controlled situations, especially when other choices are too expensive or unavailable. I read a study from Brazil showing it outpaced aspirin or acetaminophen in specific cases. In these regions, some rely on it because it’s cheap and effective on pain. But the stories about side effects never went away. Rules about monitoring patients for blood problems are strict, but health systems with fewer resources struggle to keep up.
Aminopyrine’s story shows what happens when a drug’s benefits clash head-on with its risks. The urge to kill pain quickly can compete with the need for safety. I remember treating patients who used older medications, and monitoring them closely for warning signs other doctors missed. Over time, we have better choices with clear safety profiles. People expect pain relief — but also expect not to trade one problem for another.
Some researchers keep looking at aminopyrine, especially in labs, to learn more about how it targets signals in the brain. Others dig into its chemistry, hoping to create safer cousins that deliver the punch without the kickback. Education about the dangers lags behind in some places. Better guidelines, reliable blood monitoring, and awareness about safer alternatives could help.
Pain never becomes easier to treat, but trust in medicine can shatter overnight when harm outweighs benefit. Aminopyrine once ruled as a painkiller. Today, its cautionary tale reminds us that every quick fix carries a legacy.
Aminopyrine played a role as a painkiller and fever reducer in the early days of modern medicine. Doctors once wrote prescriptions for it as easily as acetaminophen today. Years ago, my own grandfather kept a bottle of aminopyrine tablets in the top drawer of his nightstand, ready for headaches or fierce bouts of flu. What most folks didn’t know at the time: the drug came with a streak of dangerous side effects, some of them serious enough to force regulators to pull aminopyrine from regular pharmacy shelves in many countries.
The most alarming risk linked to aminopyrine is agranulocytosis. This isn’t just a complicated medical term tossed around to scare patients. Agranulocytosis means the body stops making enough white blood cells – one of the main lines of defense against infections. Even a mild cold turns risky. If infections start when your immune system is low, recovery can take longer and could send you to the hospital. The World Health Organization listed aminopyrine among drugs with life-threatening risks for this very reason. I’ve seen a couple of rare stories where a simple fever spiraled into months of recovery because of suppressed immunity after using aminopyrine.
The problems don’t end with white blood cells. The drug has caused allergic skin reactions—red blotches, itching, even swelling. Some people found themselves gasping for breath after a dose, caught off guard by sudden and severe allergic reactions. Liver toxicity showed up in a handful of case studies, with some patients developing jaundice that lingered long after the tablets disappeared from the medicine cabinet.
I once spoke with a rural physician who remembered patchy rashes that baffled his clinic until he traced them to aminopyrine. These allergic responses sometimes fade after discontinuing the drug, but they aren’t always easy to spot right away, especially in communities where access to specialty care lags far behind the city’s pace.
Many countries banned aminopyrine decades ago, but it still circulates through informal channels, especially in parts of Asia, Latin America, and Eastern Europe. Sometimes people find it in compounded medications or as part of mixtures sold at small-town pharmacies. Fake medicines can show up, too, and when labels don’t list ingredients honestly, there’s no way to dodge unexpected side effects. Health agencies keep warning about ‘old’ drugs making a comeback, and aminopyrine usually tops that list.
Public health campaigns need to talk about these risks clearly and directly. Forget the technical jargon—footage of real patients and frank stories from survivors often have a bigger impact. Stronger regulations and better labeling standards can help, but real change sticks when patients and families understand why certain drugs drop from favor. Doctors, pharmacists, and public health workers can share practical advice about up-to-date painkillers or fever reducers that do the job without bringing so much risk along for the ride.
Every medication carries a trade-off between benefit and harm. My own family’s cautious approach to ‘old’ painkillers came after stories of side effects hit close to home. Staying informed and asking questions at the pharmacy counter can make all the difference, whether you’re in a big-city hospital or a small country clinic.
Many of us have searched our medicine cabinet looking for relief from pain or fever. Aminopyrine used to show up as a common solution, especially before the rise of newer painkillers. Today, its use deserves attention not only because of its benefits, but also because of its risks. If you don’t pay close attention to how you take aminopyrine, the drug can do more harm than good. Like most substances that mess with your immune system and blood, you can’t afford to cut corners.
This medicine was almost a household name in the middle of the last century. Doctors relied on it because it gets rid of headaches and lowers fevers quickly. Things changed once researchers found out about its rare but deadly side effects, especially a sharp drop in white blood cells. Agranulocytosis isn’t just a fancy term on a bottle—it puts people at serious risk for infection, turning a simple fever into a real emergency. Reports from the World Health Organization and several public health agencies show a link between aminopyrine and these risks, which is a big reason it’s banned in many countries.
If you live in a country where aminopyrine is still around, following your doctor's advice exactly is the only way forward. Never take a friend’s leftover dose or guess your way through the package insert. Doctors base their instructions on your weight, age, medical history, and current health. It pays to be upfront about any allergies or weird reactions to medication you’ve had in the past.
From years behind the pharmacy counter, I can say that taking aminopyrine without medical supervision just isn’t worth the gamble. Pharmacists get calls from people who shrug off a rash or sore throat while using the drug, not realizing those might be early signs of something life-threatening. If your healthcare provider prescribes aminopyrine, tell them immediately if you feel unwell. Regular blood checks often help spot problems before they erupt.
Aminopyrine usually comes in tablet or injectable forms. Always swallow the tablets with water and never crush or split them unless your doctor tells you to. Missing a dose or doubling up because you “forgot” raises your risk—taking pain medicine with a casual attitude doesn’t mix. Food can affect how your body handles some medicines, so only take it with meals if that’s what your doctor says.
Mixing aminopyrine with alcohol or other drugs – even something as simple as cold medicine – can lead to complications. Common sense helps here, but nothing beats asking a healthcare professional directly before you make any choices. Keep the drug away from kids and never share it, even if someone complains of symptoms like yours.
Many problems come from lack of information. Pharmacies and doctors need to keep stressing how serious aminopyrine side effects can get. Printed reminders and easy-to-understand guides in local languages would help, especially in places where people still take this medicine. The best way for all of us to stay healthy is to ask questions at the pharmacy, stay aware of our own health, and avoid treating prescription drugs like casual over-the-counter options.
When you focus on communication and follow trusted advice, risks from old-school drugs like aminopyrine become less daunting. Ultimately, the responsibility falls on both patients and healthcare teams to keep safety at the center of every decision.
Aminopyrine once filled pharmacy shelves as a go-to pain reliever and fever reducer. Over the years, worries about side effects sent its use into steep decline in many countries. These days, very few doctors still reach for aminopyrine – and there are strong reasons behind that, especially for anyone expecting a baby or breastfeeding.
Stories from the past often point to rare but severe blood problems called agranulocytosis after aminopyrine use. The risk gets even more troubling during pregnancy or breastfeeding. Research shows that aminopyrine crosses the placenta. Any medicine crossing over has a real shot at ending up in the baby’s system. Scientists worry about effects on bone marrow, since newborns are much more sensitive than adults.
Animal tests add more worries. Giving aminopyrine to pregnant rats led to stunted growth and even birth defects in some cases. Rats aren’t people, but those findings make it hard to shake off concerns about possible harm to human babies.
Nursing mothers pass many medicines through breastmilk. Studies have spotted aminopyrine and its breakdown products in human milk. Little ones don’t process drugs the same way adults do, so even a small dose can last longer or hit harder. Experts simply do not have enough studies to prove aminopyrine is safe during breastfeeding.
Modern medicine offers alternatives that doctors trust a lot more for pain and fevers. Acetaminophen and ibuprofen both have long-term safety records for pregnant and breastfeeding women, as long as they follow dosing rules. Guidelines from groups like the World Health Organization highlight these choices for a reason: proven safety, tested and checked in huge studies, and a low chance of harm.
Outdated guidance often sticks around in some corners, but staying current protects families. Health authorities, including the U.S. Food and Drug Administration, pulled their support for aminopyrine decades ago. Many countries banned or severely restricted its use. If a patient still receives aminopyrine as advice, it helps to pause and ask for a second opinion. Confidence in a medicine comes from real data, not old habits.
Anyone considering any medicine during pregnancy or breastfeeding faces a tough job. Each mom wants to keep her child safe, but pain and fever still need treatment. The clear answer: talk it through in detail with a trusted healthcare provider. Ask tough questions, look for up-to-date facts, and insist on options with proven safety records. FDA pregnancy categories no longer apply, but most Western specialists strongly advise against aminopyrine.
When it comes to your health and your baby’s well-being, speak up, double-check the facts, and always reach for medicines with a history of safe use. If in doubt, skip the old remedies like aminopyrine and reach for those trusted by current science.
Aminopyrine once landed on pharmacy shelves for pain and fever relief. Some older folks may remember doctors handing out this drug decades ago, right alongside aspirin, for everything from toothaches to colds. Medical advice has shifted a lot since then, especially after cases popped up linking aminopyrine to a rare, sometimes deadly blood problem called agranulocytosis. It's that risk, and questions about mixing medicines, that keeps this drug in medical conversations.
Drug interactions don’t always make headlines until someone gets hurt. Years ago, some doctors mixed aminopyrine with other painkillers or caffeine, hoping for a stronger or longer-lasting effect. Trouble started when hospital reports shared stories of patients running into dangerous drops in white blood cells. The most serious risk comes when people take aminopyrine with medicines that also suppress the immune system. Sulfa drugs, some antibiotics like chloramphenicol, or even chemotherapy drugs can double down on that blood cell drop. Mixing these isn’t just a bad idea, it can be life-threatening.
Blood thinners like warfarin bring their own problems. Aminopyrine can change the way the liver handles these medicines, meaning the effects of blood thinners can spike or drop without warning. Suddenly, a mild headache remedy turns into a bleeding danger. The same goes for seizure drugs or those for epilepsy—aminopyrine can lower how well these work, risking unplanned seizures.
Few drugstores in the US or Europe carry aminopyrine anymore, and most doctors have stopped prescribing it for good reason. Travel changes things though. Some folks pick up medicine abroad, not knowing what it is, or order pills online from websites that don’t always check safety standards. Without proper labels or oversight, someone could mix aminopyrine with other prescriptions by accident.
There’s also the issue of older people with a medicine cabinet full of bottles for chronic pain, high blood pressure, and more. One extra pill, tossed in for a headache, might seem harmless. But if aminopyrine’s in the mix, the risks jump up fast, especially with age-related changes to liver or kidney function.
Clear information saves lives, plain and simple. Pharmacists and doctors need to check every medicine a patient takes—not just the prescribed ones—especially if someone travels or shops online for drugs from overseas. Patient education means more than just a warning label. Real talk, face-to-face, about exactly what could happen if aminopyrine slips into their medicine routine. Keeping a running list of all medicines, sharing it with healthcare providers, and tossing out any uncertified medicine forms a strong first line of defense.
Healthcare clinics also play a big role by updating their electronic records to flag aminopyrine and its dangerous cousins. Systems can be set up to alert pharmacists or prescribers the second a high-risk combination comes up. These simple reminders can prevent serious, even deadly mistakes.
Aminopyrine stands as an example of how much progress medicine has made and why digging a little deeper into what’s inside your pill bottle matters for everyone. It’s easy to trust what’s on the label, but a smart patient asks questions and keeps an open line with their healthcare team. Blending medicines can turn everyday aches into emergencies, so that conversation about drug interactions shouldn’t get left in the past.
| Names | |
| Preferred IUPAC name | 4-Dimethylamino-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one |
| Other names |
Aminophenazone Amidopyrine Pyramidon Piramidon Piramidonum 4-Dimethylaminoantipyrine |
| Pronunciation | /əˌmiː.nəˈpaɪriːn/ |
| Identifiers | |
| CAS Number | 58-15-1 |
| Beilstein Reference | 82227 |
| ChEBI | CHEBI:2677 |
| ChEMBL | CHEMBL137 |
| ChemSpider | 5796 |
| DrugBank | DB01436 |
| ECHA InfoCard | 100.002.430 |
| EC Number | 3.5.2.19 |
| Gmelin Reference | 69038 |
| KEGG | C02947 |
| MeSH | D000654 |
| PubChem CID | 2117 |
| RTECS number | UY4375000 |
| UNII | 4TSW8T9929 |
| UN number | UN2811 |
| Properties | |
| Chemical formula | C13H17N3O |
| Molar mass | 303.36 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | 1.2 g/cm³ |
| Solubility in water | slightly soluble |
| log P | 1.09 |
| Vapor pressure | 0.0000297 mmHg at 25°C |
| Acidity (pKa) | 5.3 |
| Basicity (pKb) | 5.10 |
| Magnetic susceptibility (χ) | -74.0 × 10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.616 |
| Viscosity | 2.2 mPa·s |
| Dipole moment | 3.61 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 324.3 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -20.8 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -3657 kJ mol⁻¹ |
| Pharmacology | |
| ATC code | N02BB05 |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes damage to blood and liver. May cause allergic reactions. |
| GHS labelling | GHS02, GHS07 |
| Pictograms | GHS06,GHS08 |
| Signal word | Warning |
| Hazard statements | H301 + H351 + H341 + H373 |
| Precautionary statements | P264, P270, P301+P312, P330, P405, P501 |
| NFPA 704 (fire diamond) | 2-1-1-W |
| Flash point | 52°C |
| Autoignition temperature | 525 °C |
| Lethal dose or concentration | LD50 oral rat 860 mg/kg |
| LD50 (median dose) | LD50 (median dose): 2,200 mg/kg (oral, rats) |
| NIOSH | RN:58-15-1 |
| PEL (Permissible) | PEL: Not Established |
| REL (Recommended) | 0.3-1g each time, 2-3 times daily |
| Related compounds | |
| Related compounds |
4-Dimethylaminophenazone Dipyrone Antipyrine |
